Not many days to left in Septmeber. Fingers crossed!Here are...

Not many days to left in Septmeber. Fingers crossed!

Here are some snippets from RBS, with PYC mentioned.



Near-term milestones to watch
*****************************

* Acrux (ACR) - 2HCY11 - Patent extension for under-arm application.
* Alchemia (ACL) - 4QCY11 - Start Phase III trial for HA-Irinotecan.
* Biota (BTA) - 2HCY11 - Outcome of ROW LANI negotiations with Daiichi.
* Impedimed (IPD) - Dec 2011 - Securing 20m covered lives with US insurance companies.
* Pharmaxis (PXS) - Oct 2011 - European regulatory appeal decision.
* Phylogica (PYC) - Sep 2011 - Sign deal with large pharma.
* Psivida (PVA) - Nov 12, 2011 - Expected PDUFA date.
* QRX Pharma (QRX) - 2HCY11 - Expect partnering deal with pharma.
* Sunshine Heart (SHC) - Achieved - Release of 20-patient feasibility results.
* Tissue Therapies (TIS) - 2HCY11 - Sign licensing deal with large wound-care company.

*****

Source: RBS Morgans, Company Data
Scott Power (+61 7 3334 4884) & Tanya Solomon (+61 7 3334 4521)

(Note that Biotech & Healthcare Weekly Snippets provides a summary of views only. Full reports can be found at www.rbsmorgans.com).